Skip to main content

What type of prostate cancer is Erleada used to treat?

Medically reviewed by Drugs.com. Last updated on Sep 11, 2023.

Official answer

by Drugs.com

Erleada (apalutamide) is used for the treatment of metastatic castration-sensitive prostate cancer and non-metastatic castration-resistant prostate cancer.

Metastatic castration-sensitive prostate cancer (mCSPC) refers to prostate cancer that still responds to androgen deprivation therapy (ADT) and has spread to other parts of the body.

Non-metastatic castration-resistant prostate cancer (NM-CRPC) refers to prostate cancer that no longer responds to androgen deprivation therapy (ADT) or surgical treatments that lower testosterone, but has not yet been discovered in other parts of the body.

Erleada is an androgen receptor inhibitor. It works by blocking the effect of androgens on the tumor. Androgens, such as testosterone, can promote tumor growth.

Erleada is taken orally, once daily, with or without food.

Read next

Doxorubicin is considered one of the strongest chemotherapy drugs for breast cancer ever invented. It can kill cancer cells at every point in their life cycle, and it's used to treat a wide variety of cancers, not just breast cancer. Doxorubicin is also known as “The Red Devil” because it is a clear bright red color. It can cause your urine or other body fluids to turn a reddish color for 1 to 2 days after a dose is given, which is normal and temporary. Continue reading

Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading

A hereditary family history of lung cancer is one of the many risk factors for developing non-small cell lung cancer. About 8% of lung cancers are thought to be inherited or linked to gene changes, but smoking and air pollution remain the primary causes of lung cancer. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer